<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="31910">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02691273</url>
  </required_header>
  <id_info>
    <org_study_id>NM01-HMO-CTIL</org_study_id>
    <nct_id>NCT02691273</nct_id>
  </id_info>
  <brief_title>Applicability of Cellular Application in Diabetes Type 2 Patients.</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hadassah Medical Organization</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It was found that an important part of the factors impeding adherence to medication and a
      healthy lifestyle among the chronically ill diabetic patients lies in proper management of
      the disease. Since it is a chronic progressive disease the caregiver is the patient
      himself.Studies have shown that software system, sending text messages / messages /
      reminders daily and answering questionnaires can improve adherence to a change in lifestyle.

      This study is an initial pilot study , which examines Feasibility ( Applicability ) of using
      a smart application that promotes a healthy lifestyle perseverance parallel use relaxation
      techniques .
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2015</start_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>10 percentage improvement in the quality of life questionnaire</measure>
    <time_frame>two months</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>breathing technique</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>this arm includes learning breathing technique using the patient's smartphone.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>cellular application treating diabetes using breathing technique</intervention_name>
    <arm_group_label>breathing technique</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  HbA1c above 7.5.

          -  Smartphone users.

          -  English and Hebrew literate.

        Exclusion Criteria:

        *Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Avivit Cohen</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hadassah Medical Organization</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hadas Lamberg</last_name>
    <email>lhadas@hadassah.org.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hadassah Medical Organization</name>
      <address>
        <city>Jerusalem</city>
        <zip>9112-</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <lastchanged_date>February 21, 2016</lastchanged_date>
  <firstreceived_date>January 20, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
